Login
Search manual

Details

Title PHARMACEUTICAL SCIENCES: breakthroughs in research and practice.
Imprint HERSHEY: MEDICAL INFOR Science IGI, 2017
Collection Электронные книги зарубежных издательств ; Общая коллекция
Subjects Drug development. ; Pharmaceutical industry. ; BUSINESS & ECONOMICS / Industries / General ; EBSCO eBooks
Document type Other
Language English
Rights Доступ по паролю из сети Интернет (чтение, печать, копирование)
Record key ocn967767552
Record create date 1/6/2017

Allowed Actions

pdf/1447283.pdf –
Action 'Read' will be available if you login or access site from another network Action 'Download' will be available if you login or access site from another network
epub/1447283.epub –
Action 'Download' will be available if you login or access site from another network
Group Anonymous
Network Internet
Network User group Action
ILC SPbPU Local Network All
Read Print Download
Internet Authorized users SPbPU
Read Print Download
Internet Anonymous
  • Title Page
  • Copyright Page
  • List of Contributors
  • Table of Contents
  • Preface
  • Section 1: Clinical Trials, Education, and Information Access
    • Chapter 1: Overview of Clinical Trial and Pharmacovigilance Process and Areas of Application of Computer System
    • Chapter 2: Pharmacogenomics Genome Wise Association Clinical Studies
    • Chapter 3: Normalizing Cross-Border Healthcare in Europe via New E-Prescription Paradigms
    • Chapter 4: Web 2.0 Tools in Biomedical and Pharmaceutical Education
    • Chapter 5: Open Access Initiatives in Medical Biology
  • Section 2: Drug Delivery and Patient Care
    • Chapter 6: Application of Nanoparticles as a Drug Delivery System
    • Chapter 7: Non-Ionic Surfactant Vesicles (Niosomes) as New Drug Delivery Systems
    • Chapter 8: Cancer Drug Delivery
    • Chapter 9: CNS Targeted Nanoparticle Drug Delivery
    • Chapter 10: Engineered Gellan Polysaccharides in the Design of Controlled Drug Delivery Systems
    • Chapter 11: Improving Pharmaceutical Care through the Use of Intelligent Pharmacoinformatics
    • Chapter 12: Personalized Medicine in the Era of Genomics
    • Chapter 13: Role of Resveratrol (RES) in Regenerative Medicine
    • Chapter 14: Strategies for Expanding Access and Improving the Quality of Pharmaceutical Services
    • Chapter 15: An Overview of Therapeutic Applications
    • Chapter 16: Bioinformatics and Its Therapeutic Applications
    • Chapter 17: A Perspective on the Phytopharmaceuticals Responsible for the Therapeutic Applications
    • Chapter 18: Resealed Erythrocytes as Drug Carriers and Its Therapeutic Applications
    • Chapter 19: Sedation and Analgesia
  • Section 3: Functional Foods
    • Chapter 20: Phytonutrients of Nutraceutical Importance
    • Chapter 21: Prediction of Structural and Functional Aspects of Protein
    • Chapter 22: Flavonoids
    • Chapter 23: Food Allergy and Food Poisoning
    • Chapter 24: Food and Cardiac Health
  • Section 4: Molecular Modeling and Drug Design
    • Chapter 25: Molecular-Docking-Based Drug Design and Discovery
    • Chapter 26: Role of Molecular Docking in Computer-Aided Drug Design and Development
    • Chapter 27: Molecular-Docking-Based Anti-Allergic Drug Design
    • Chapter 28: Molecular Docking Technique to Understand Enzyme-Ligand Interactions
    • Chapter 29: Molecular Modelling, Dynamics, and Docking of Membrane Proteins
    • Chapter 30: Molecular Docking Challenges and Limitations
    • Chapter 31: Different Types of Molecular Docking Based on Variations of Interacting Molecules
    • Chapter 32: The Comparison of Docking Search Algorithms and Scoring Functions
    • Chapter 33: Application of Docking Methodologies in QSAR-Based Studies
    • Chapter 34: Protein Structure Prediction Using Homology Modeling
    • Chapter 35: QSAR Studies on Bacterial Efflux Pump Inhibitors
    • Chapter 36: QSPR/QSAR Analyses by Means of the CORAL Software
    • Chapter 37: 2D and 3D QSAR Studies on a Series of Antichagasic Fenarimol Derivatives
    • Chapter 38: The “ETA” Indices in QSAR/QSPR/QSTR Research
    • Chapter 39: Importance of Applicability Domain of QSAR Models
    • Chapter 40: Molecular Dynamics Simulations for Biological Systems
    • Chapter 41: Protein Ligand Interaction Fingerprints
    • Chapter 42: Protein-Protein Docking
    • Chapter 43: Protein-Protein Interactions (PPIs) as an Alternative to Targeting the ATP Binding Site of Kinase
    • Chapter 44: Rational Drug Design Rational Drug Design
    • Chapter 45: Smart, Innovative and Intelligent Technologies Used in Drug Designing
  • Section 5: Nanostructures and Technology
    • Chapter 46: Hybrid Plasmonic Nanostructures
    • Chapter 47: Implementation of Nanoparticles in Cancer Therapy
    • Chapter 48: Nanomedicine
    • Chapter 49: Nanosuspensions in Nanobiomedicine
    • Chapter 50: Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials
    • Chapter 51: QSAR-Based Studies of Nanomaterials in the Environment
    • Chapter 52: Stratagems of Nanotechnology Augmenting the Bioavailability and Therapeutic Efficacy of Traditional Medicine to Formulate Smart Herbal Drugs Combating
  • Section 6: Toxicology
    • Chapter 53: Toxic Effects of Engineered Nanoparticles on Living Cells
    • Chapter 54: Cyanobacterial Toxins in Water Sources and Their Impacts on Human Health
    • Chapter 55: Pharmaceuticals and Personal Care Products as Emerging Water Contaminants
    • Chapter 56: Toxicological Effects of Carbon Nanotubes
    • Chapter 57: Understanding Toxicity of Nanomaterials in Biological Systems
    • Chapter 58: Quantitative Structure-Activity/Property/Toxicity Relationships through Conceptual Density Functional Theory-Based Reactivity Descriptors
    • Chapter 59: Quasi-SMILES for Nano-QSAR Prediction of Toxic Effect of Al2O3 Nanoparticles
  • Index
...